Article
An improved digital polymerase chain reaction protocol to capture low-copy KRAS mutations in plasma cell-free DNA by resolving 'subsampling' issues.
Molecular oncology - 1 Oct 2017
Ono Yusuke, Sugitani Ayumu, Karasaki Hidenori, Ogata Munehiko, Nozaki Reo, Sasajima Junpei, Yokochi Tomoki, Asahara Shingo, Koizumi Kazuya, Ando Kiyohiro, Hironaka Katsunori, Daito Tsutomu, Mizukami Yusuke
Abstract excerpt
Genetic alterations responsible for the initiation of cancer may serve as immediate biomarkers for early diagnosis. Plasma levels of cell-free DNA (cfDNA) in patients with cancer are higher than those in healthy individuals; however, the major technical challenge for the widespread implementation of cfDNA genotyping as a diagnostic tool is the insufficient sensitivity and specificity of detecting early-stage...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
